Morgan Stanley Assumes DexCom at Equal-Weight, Announces Price Target of $131
Portfolio Pulse from richadhand@benzinga.com
Morgan Stanley analyst Patrick Wood assumes DexCom (NASDAQ:DXCM) with an Equal-Weight rating and announces a price target of $131.
May 30, 2023 | 11:35 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Morgan Stanley assumes DexCom with an Equal-Weight rating and a price target of $131.
Morgan Stanley's Equal-Weight rating for DexCom suggests a neutral outlook for the stock in the short term. The price target of $131 indicates the analyst's expectation for the stock's performance. This news is directly related to DexCom and is important for investors, but the neutral rating suggests no significant short-term price movement.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100